nGageIT Announces Digital Health Product, Checks Adherence Through Users’ Breath

Toronto-based nGageIT announced the launch of its latest digital health product, NanoSmart. The product uses an individual's breath to determine their medication adherence. The platform includes a biosensor detection technology called the “Noz,” which can fit into their smartphone. According to Jennifer Murdoch, chief operations officer and co-founder of nGageIT, the goal is to provide real-time information to better understand how much and when an opioid is taken to ultimately prevent dependency and addictive behavior before it occurs.

When an individual breathes into the Noz, the dongle is able to pick up on the ingestible nanoparticles . . .